2014
DOI: 10.1021/ml500459f
|View full text |Cite
|
Sign up to set email alerts
|

Potent Irreversible Inhibitors of LasR Quorum Sensing in Pseudomonas aeruginosa

Abstract: Antagonism of quorum sensing represents a promising new antivirulence approach for the treatment of bacterial infection. The development of a novel series of non-natural irreversible antagonists of P. aeruginosa LasR is described. The lead compounds identified (25 and 28) display potent LasR antagonist activity and inhibit expression of the P. aeruginosa virulence factors pyocyanin and biofilm formation in PAO1 and PA14.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
40
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 53 publications
(42 citation statements)
references
References 34 publications
2
40
0
Order By: Relevance
“…Third, we have provided a considerable number of co-crystal structures (nine in total) for the LasR-LBD bound to non-native ligands. In view of the growing interest in the TP scaffold (Capilato et al, 2017; O’Brien et al, 2015; O’Reilly and Blackwell, 2016) and QS in P. aeruginosa in general (Papenfort and Bassler, 2016; Welsh and Blackwell, 2016b), these structures are of fundamental interest. Fourth, we propose a mechanism for LasR activation and signal transduction that implicates the L3 loop as a possible gatekeeper for productive protein folding, dynamically opening and closing in the absence of ligand to provide entry to the ligand-binding pocket.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Third, we have provided a considerable number of co-crystal structures (nine in total) for the LasR-LBD bound to non-native ligands. In view of the growing interest in the TP scaffold (Capilato et al, 2017; O’Brien et al, 2015; O’Reilly and Blackwell, 2016) and QS in P. aeruginosa in general (Papenfort and Bassler, 2016; Welsh and Blackwell, 2016b), these structures are of fundamental interest. Fourth, we propose a mechanism for LasR activation and signal transduction that implicates the L3 loop as a possible gatekeeper for productive protein folding, dynamically opening and closing in the absence of ligand to provide entry to the ligand-binding pocket.…”
Section: Discussionmentioning
confidence: 99%
“…By scrutinizing the LasR-LBD structural data in concert with prior activity data for AHL-derived LasR antagonists (Amara et al, 2009; Galloway et al, 2011; Geske et al, 2007), various laboratories have sought to develop TP-derived compounds that antagonize LasR (Fig. 1B) (Capilato et al, 2017; O’Brien et al, 2015; O’Reilly and Blackwell, 2016). The antagonists identified in these past studies are among the most potent LasR antagonists known; however, they are orders of magnitude less potent than LasR’s native ligand or TP1 (i.e., micromolar IC 50 values relative to nanomolar EC 50 values for OdDHL and TP1 ).…”
Section: Introductionmentioning
confidence: 99%
“…The proximity of Cys 79 to the terminal carbon of 3O-C 12 -HSL (22) (Fig. 1B) suggests that this thiol might be important for ligand recognition, and others have reported covalent modification of Cys 79 when LBD is expressed in the presence of electrophilic probes derived from the native AHL structure, placing reactive functional groups proximal to the thiol (34,35). Cys 79 appears to be most sensitive to oxidative stress when not bound to its native ligand, and perhaps the dimer observed by SDS-PAGE ( Fig.…”
Section: Impact Of Oxidative Stress On the Lasr Ligand Binding Domainmentioning
confidence: 94%
“…Our results add to this intriguing interkingdom chemical communication cross-talk by demonstrating that LXA 4 , with primary activity in the resolution of inflammatory signaling in the host, inhibits the activity of a bacterial QS receptor, LasR, and decreases the expression of virulence factors in this bacteria. The potency of this inhibition by LXA 4 as evaluated by comparing IC 50 values is several orders of magnitude greater than any reported LasR antagonist (77) and occurs at physiologically relevant concentrations of LXA 4 (64). Of interest, LXA 4 is not only an antagonist but it also has partial agonist activity against LasR (Fig.…”
Section: Discussionmentioning
confidence: 87%